Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss [NA]

View source ↗

Summary

Clinical trial evaluating the role of low-molecular-weight heparin in unexplained recurrent pregnancy loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: RESnTEC, Institute of Research | Conditions: Pregnancy Loss | NA | Status: COMPLETED